Dupuytren Concrature
Conditions
Brief summary
Recurrence, defined as ≥20° passive extension deficit in metacarpophalangeal joint
Detailed description
%-change in metacarpophalangeal (MCP) joint passiv exension deficit (PED), Straight MCP joint (0-5°), Passive extension deficit of MCP, PIP, DIP-joints, Total passive extension deficit, Maximal pulp-to-palm distance (mm), Tabletop test, Complications and Adverse Events (AEs), Reoperation, PROM score: "quick-DASH", "Southhampton Dupuytren Scoring Scheme", EQ-5D (EuroQol five dimension scale) for cost-benefit analysis, Global rating of change scale for patient satisfaction
Interventions
DRUG2 ml of isotonic saline injection (9 mg/ml)
DRUGXYLOCAINE 10 mg/ml SANS CONSERVATEUR
DRUGsolution injectable
Sponsors
Region Midtjylland
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Recurrence, defined as ≥20° passive extension deficit in metacarpophalangeal joint | — |
Secondary
| Measure | Time frame |
|---|---|
| %-change in metacarpophalangeal (MCP) joint passiv exension deficit (PED), Straight MCP joint (0-5°), Passive extension deficit of MCP, PIP, DIP-joints, Total passive extension deficit, Maximal pulp-to-palm distance (mm), Tabletop test, Complications and Adverse Events (AEs), Reoperation, PROM score: "quick-DASH", "Southhampton Dupuytren Scoring Scheme", EQ-5D (EuroQol five dimension scale) for cost-benefit analysis, Global rating of change scale for patient satisfaction | — |
Countries
Denmark
Outcome results
None listed